KRKozhiparambil Gopalan Raghu

Kozhiparambil Gopalan Raghu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kozhiparambil Gopalan Raghu has a total of 138 co-authors. Here are the top co-authors by number of shared publications:

  • Anupama Nair

    Biochemistry and Molecular Mechanism Laboratory, Agro-processing and Technology Division, Council of Scientific and Industrial Research (CSIR) - National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, 695019, Kerala, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India

    8 shared publications
  • M.R. Preetha Rani

    Biochemistry and Molecular Mechanism Laboratory, Agro-Processing and Technology Division, CSIR - National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, Kerala 695019, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC Campus, Ghaziabad, Uttar Pradesh 201002, India

    7 shared publications
  • Nair Anupama

    Biochemistry and Molecular Mechanism Laboratory, Agro-processing and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram 695,019, Kerala, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-HRDC Campus, Ghaziabad, Uttar Pradesh 201,002, India

    6 shared publications
  • A. Prathapan

    Biochemistry and molecular mechanism laboratory, Agro-Processing and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram - 695019, Kerala, India

    5 shared publications
  • R. S. Soumya

    Biochemistry and Molecular Mechanism Laboratory, Agro Processing and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, India

    5 shared publications
  • Rema Sreenivasan Soumya

    Biochemistry and Molecular Mechanism Laboratory, Agroprocessing and Technology Division, CSIR- National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, Kerala, India

    5 shared publications

Latest Publications

  • Synthesis, characterization, and biophysical and chemical properties of benzo[ b ]thiophene derivatives and their metal complexes

    by T. M. Dhanya, K. J. Rajimon, Jibin K. Varughese, K. G. Raghu, G. Anjali Krishna, Sachin Philip, Saumya S. Pillai, P. A. Rineesh, Priya Breitener, P. V. Mohanan

    New effective antioxidant, antimicrobial, anti-inflammatory, enzyme-inhibiting, and cytotoxic agents with novel modes of action are urgently needed due to the continued emergence of various diseases. Four novel Schiff base ligands containing a benzo[b]thiophene moiety were synthesized, leading to the development of a versatile class of Ni(II) and Mn(II) complexes, which were screened for their biological applications. The Schiff base ligands were characterized quantitatively using standard spectroscopic techniques such as elemental analysis, UV-vis spectroscopy, FT-IR spectroscopy, LC-MS, 1H NMR spectroscopy and 13C NMR spectroscopy, while the metal complexes were characterized using UV-vis spectroscopy, FT-IR spectroscopy, CHNS analysis, ICP-MS, thermal analysis (TG and DTG), molar conductance and magnetic susceptibility measurements. The coordination structure of the complexes was found to be octahedral geometry, with Ni(II) and Mn(II) metal ions coordinated to a nitrogen atom of azomethine group, a benzo[b]thiophene ring, an oxygen atom of the phenolic group and an acetate derivative. Among the synthesized compounds, the biological properties of the complexes were found to be more potent than those of Schiff base ligands. Their antioxidant, antibacterial, anti-inflammatory, enzyme inhibitory, and cytotoxic activities were assessed. The antioxidant activity of the developed compounds was tested using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay in methanol and buffered methanol solutions. All the Schiff base ligands and their Ni(II)/Mn(II) complexes exhibited antioxidant activities comparable to the standards (BHT and ascorbic acid). The in vitro antibacterial activity of the synthesized compounds was evaluated against Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Bacillus subtilis (B. subtilis), and Staphylococcus aureus (S. aureus) and their antifungal activity using fungal strains, such as Aspergillus niger (A. niger), and Candida albicans (C. albicans). These activities were observed using the agar disc diffusion method, with ciprofloxacin and nystatin as the reference drugs. The HRBC membrane stabilization method was applied to measure anti-inflammatory activity, and one of the Mn(II) compounds showed moderate anti-inflammatory activity, which was compared with the standard drug diclofenac. Enzyme inhibition studies were conducted on benzo[b]thiophene-derived Schiff base ligands and their complexes with the enzyme α-amylase, using acarbose as the standard. The Ni(II) complexes exhibited the best enzyme inhibition value (Ki). To assess the cytotoxic behavior of the synthesized compounds and determine cell viability, two methods were used: the trypan blue exclusion method for cancer cell lines, such as DLA cells and HepG2 cells, and the MTT assay for human cells, such as H9c2 cells. Encouragingly, most of the compounds were generally non-toxic to the human cells (H9c2).


  • Unveiling the multifaceted bioactivity of copper( ii )–Schiff base complexes: a comprehensive study of antioxidant, anti-bacterial, anti-inflammatory, enzyme inhibition and cytotoxic potentials with DFT insights

    by T. M. Dhanya, M. R. Prathapachandra Kurup, K. J. Rajimon, G. Anjali Krishna, Jibin K. Varughese, K. G. Raghu, Sachin Philip, K. M. Divya, Maria Augustine, P. V. Mohanan

    The rise of various diseases demands the development of new agents with antioxidant, antimicrobial, anti-inflammatory, enzyme-inhibiting, and cytotoxic properties. In this study, heterocyclic Schiff base complexes of Cu(II) featuring a benzo[b]thiophene moiety were synthesized and their biological activities evaluated. The complexes were characterized using FT-IR, UV-Vis, and EPR spectroscopy, TG–DTG analysis, magnetic moment measurements, molar conductivity measurements, and elemental analyses. Density functional theory (DFT) calculations were used to optimize the theoretical molecular orbital energies of the copper complexes. The complexes exhibited square pyramidal and square planar geometries. Biological assays demonstrated that these complexes generally outperformed the Schiff base ligands for various activities. The antioxidant capacity, measured via the DPPH assay in methanol, was comparable to those of the BHT and ascorbic acid standards, with 4BNPC showing the lowest IC50 value, which was attributed to the free OH group rather than coordination to the metal center. The anti-bacterial activity was assessed using the agar disc diffusion method against E. coli, P. aeruginosa, B. subtilis, and S. aureus, with BAC showing the largest inhibition zone compared to the others and ciprofloxacin as the reference. The anti-inflammatory activity, evaluated by the HRBC membrane stabilization method, showed that the 4BNPC Cu(II) complex had moderate activity similar to that of diclofenac. Enzyme inhibition studies against α-amylase revealed that the BAC complexes had the highest inhibition values, surpassing those of the Schiff base ligands. Cytotoxicity was assessed using Trypan blue exclusion for DLA and HepG2 cancer cell lines, and the MTT assay for H9c2 human cells. BMPC demonstrated superior cytotoxicity at both high and low concentrations against the normal H9c2 cell line. Among the tested compounds, BNPC showed moderate inhibition against HepG2 cells, while BMPC exhibited the greatest cytotoxicity at higher concentrations, particularly reaching nearly 100% cell death at 200 μg mL−1 in DLA cell lines. This suggests that BMPC is a promising candidate for further pharmacological research, particularly against DLA cells.


  • In vitro and in vivo anti-inflammatory and anti-arthritic effect of Tinospora cordifolia via modulation of JAK/STAT pathway

    by Genu George, G. L. Shyni, Sreelekshmi Mohan, Billu Abraham, P. Nisha, S. Ranjith, K. Rajankutty, K. G. Raghu

    Background Rheumatoid arthritis (RA) is a chronic inflammatory disorder causing cartilage and joint degeneration. In spite of the availability of several robust drugs like biologics, most of the patients are unresponsive, and reports of severe adverse effects following long-term use are also there. Subsequently the use of natural plant-based products in RA therapy is broadening over the years. Tinospora cordifolia is a widely used medicinal plant in Ayurveda against various inflammatory disorders including RA. However, there is very limited knowledge regarding the actual molecular events responsible for its therapeutic effect, and this has limited its acceptance among the professionals. Purpose To explore the anti-inflammatory and anti-arthritic effect of hydro-alcoholic extract from Tinospora cordifolia. Methods The rich polyphenol nature of the extract was elucidated using HPLC. LPS-stimulated murine macrophage cell line RAW 264.7 was used for in vitro studies, and collagen-induced arthritis (CIA) model was used for in vivo studies. Results The polyphenols in TCE were identified using HPLC. TCE effectively downregulated the level of pro-inflammatory mediators (IL-6, TNF-α, PGE2, and NO) in LPS-stimulated RAW 264.7 cells. Subsequently the upregulated expression of COX-2 and iNOS following LPS stimulation were also downregulated by TCE. Furthermore, TCE targeted the upstream kinases of the JAK/STAT pathway, a crucial inflammatory pathway. The expression of VEGF, a key angiogenic factor as well as an inflammatory mediator was also decreased following pre-treatment with TCE. The anti-arthritic effect of TCE (150 mg/kg) was evaluated in the CIA model as well. From the results of histopathology, oral administration of TCE was found to be effective in reducing the clinical symptoms of arthritis including paw edema, erythema, and hyperplasia. In vivo results validated the in vitro results and there was a significant reduction in serum level of pro-inflammatory cytokines and mediators (IL-6, TNF-α, IL-17, NO, and PGE2). The phosphorylation of STAT3 and the expression of VEGF were also downregulated following TCE treatment. Conclusion Our study provided a detailed insight into the molecular events associated with anti-inflammatory and anti-arthritic effect of Tinospora cordifolia.


  • Open Access

    Tangeretin alleviates Tunicamycin-induced endoplasmic reticulum stress and associated complications in skeletal muscle cells

    by Eveline M. Anto, C. R. Sruthi, Lekshmy Krishnan, K. G. Raghu, Jayamurthy Purushothaman


  • Cinnamic acid is beneficial to diabetic cardiomyopathy via its cardioprotective, anti‐inflammatory, anti‐dyslipidemia, and antidiabetic properties

    by Anupama Nair, M. R. Preetha Rani, Palayyan Salin Raj, S. Ranjit, K. Rajankutty, K. G. Raghu

    Diabetes‐related health issues are increasing day by day in public, and diabetic cardiomyopathy (DCM) is one serious issue among them. There is a lack of proper strategy to control and manage DCM. Here we are attempting a nutraceutical‐based approach to protect the heart from DCM. The beneficial effect of cinnamic acid (CiA), was evaluated in an experimental model of diabetes. For this, diabetic model was created by feeding male Wistar rats with a high fat, high fructose diet for 6 months and a single dose of streptozotocin (25 mg/kg bwt). Metformin was used as the positive control. The diabetic rats showed insulin resistance, myocardial injury, and a significant increase of total cholesterol, triglycerides, and LDL. Development of DCM was evident from the increased cardiac mass index, LDH, CKMB, ANP, and CRP levels in the diabetic group. There was a significant increase in the levels of cardiac hypertrophy markers like TGF‐β and β‐MHC in the hearts of diabetic rats revealing DCM. Pro‐inflammatory cytokines (TNF‐α, IL‐6) and lipid peroxides were significantly elevated in the serum of diabetic rats. Histopathology revealed inflammation and necrosis in the heart of diabetic rats confirming DCM. Oral administration of CiA (5 and 10 mg/kg bwt) prevented the development of DCM via its cardioprotective, anti‐inflammatory, anti‐dyslipidemia potential, and antidiabetic properties. Similarly, metformin (50 mg/kg bwt) has also shown protection against DCM. We conclude from this study that CiA is found to be beneficial against DCM and recommend more detailed preclinical and clinical studies to develop CiA‐based nutraceutical against DCM.


  • Recent advances on nanoparticle-based therapies for cardiovascular diseases

    by Rema Sreenivasan Soumya, Kozhiparambil Gopalan Raghu